Tagged with Manufacturing

LatAm Some of the top recent stories out of Latin America’s dynamic pharmaceutical and healthcare market. In Mexico, President Claudia Sheinbaum announced new investments from four leading Mexican pharmas totalling USD 560 million; a worrying new report from the Pan-American Health Organisation showing that measles cases are up 29-fold in the…

Hong Kong In summer 2023, Hong Kong entered the next frontier of cancer care with the launch of its first hospital-based CAR-T clinical trial. Developed entirely within city limits by a team of clinicians and scientists at the Chinese University of Hong Kong (CUHK), Prince of Wales Hospital, and the Hong Kong…

Puerto Rico Rolando Torres, Chief Operations Officer for CooperVision, a division of global medical device company CooperCompanies, discussed the significant growth and investment CooperVision has experienced in Puerto Rico since 2019, including expansions in manufacturing, packaging, and a workforce increase from 1,700 to nearly 2,500 employees. He highlighted the company’s $500 million…

Puerto Rico Elba Cruz, Site Director at Haleon Puerto Rico, shares how the Guayama facility has become a critical manufacturing hub for Haleon’s global operations, driven by a skilled local workforce, robust technical capabilities, and strong community pride in Puerto Rican manufacturing. Despite challenges like energy costs and talent retention, Cruz highlights…

Switzerland Luc Henry, co-founder and CEO of Limula, speaks about the challenges and opportunities in the field of cell and gene therapy. A chemist by training, Henry’s path from molecular sciences to cancer immunology and ultimately to entrepreneurship reveals how interdisciplinary thinking can catalyse bold innovation. In this conversation, Henry explains…

Switzerland Thomas Bohn has led the Greater Geneva Bern area (GGBa) investment agency for over a decade, shaping Switzerland’s strategy to attract global life sciences firms. He focuses on quality over quantity, targeting high-potential biotech, pharma, and medtech companies and supporting their European growth through sustainable partnerships. Switzerland’s life sciences heritage…

Mexico In her latest strategy to tackle Mexico’s persistent medicine shortages – a struggle inherited from predecessor López Obrador – President Claudia Sheinbaum has issued a decree that seeks to attract foreign biopharma investment. By promising international companies a better chance at winning government tenders, Sheinbaum hopes to increase domestic manufacturing,…

Puerto Rico Already a solid hub for biopharma manufacturing and logistics, Puerto Rico is moving to sharpen its position in the evolving US reshoring landscape and attract new investment. Under the banner “Made in Puerto Rico is Made in the USA,” Governor Jenniffer Gonzalez-Colon is promoting the island’s unique value as both…

France The biggest recent stories from French healthcare and the life sciences, including Sanofi’s deal to buy immunology biotech Blueprint; the largest from a European pharma this year. Elsewhere Servier is snapping up a experimental leukaemia treatment from China, while French tech firm OWKIN is touting a new “AI-powered research co-pilot”…

Hong Kong In March 2024, the Advanced Therapy Product Good Manufacturing Practice Centre (ATP GMP Centre) at the Chinese University of Hong Kong’s (CUHK) Institute of Biotechnology (HKIB) became the first university-led centre within the special administrative region to receive certification for cell and gene therapy manufacturing and a license as an…

Saudi Arabia Localising the production of medicines has become a core priority for the Saudi government over the past decade as it attempts to increase national health security, create highly skilled jobs, and grow the non-oil economy. Multinational innovators now have a wide range of incentives (as well as enforcement tactics) to…

Switzerland Combining scientific rigour with entrepreneurial instinct, Igor Fisch charts a new path for gene and cell therapy manufacturing at NewBiologix. Focused on addressing the inefficiencies of current production models, the company develops stable platforms designed to lower costs, enhance quality, and expand patient access. With roots in the pioneering success…